The predominant elF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease

Virology

Volumn 245, Issue 2, 1998, Pages 229-240

  Bovee, Michael L ^a   Marissen, Wilfred E ^a   Zamora, Miguel ^a   Lloyd, Richard E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E; PROTEINASE;

ARTICLE; CELL DIVISION; HELA CELL; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA REPLICATION; VIRUS INFECTIVITY; VIRUS REPLICATION;

ENTEROVIRUS; POLIOVIRUS; POLIOVIRUS 1; RHINOVIRUS; RNA VIRUSES;

EID: 0032486281     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9171     Document Type: Article

References (33)

1. Alvey J. C., Wyckoff E. E., Yu S. Y. F., Lloyd R., Ehrenfeld E. cistrans. J. Virol. 65:1991;6077-6083.
2. Baltera R. F., Tershak D. R. Role of amino acid residue 187 of poliovirus Polypeptide-2C in determining the guanidine trait. Intervirology. 33:1992;165-172.
3. Belsham G. J., Sonenberg N. RNA-Protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 60:1996;499.
4. Benton P. A., Murphy J. W., Lloyd R. E. K562 cell strains differ in their response to poliovirus infection. Virology. 213:1995;7-18.
5. Benton P. A., Barrett D. J., Matts R. L., Lloyd R. E. The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. J. Virol. 70:1996;5525-5532.
6. Bernstein H. D., Sonenberg N., Baltimore D. Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol. Cell. Biol. 5:1985;2913-2923.
7. Bonneau A.-M., Sonenberg N. Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection. J. Virol. 61:1987;986-991.
8. Bovee M. L., Lamphear B. J., Rhoads R. E., Lloyd R. E. Direct cleavage of eIF4G by poliovirus 2A protease is inefficientin vitro. Virology. 245:1998;241-249.
9. Brown B. A., Ehrenfeld E. Initiation factor preparations from poliovirus-infected cells restrict translation in reticulocyte lystates. Virology. 103:1980;327-339.
10. Devaney M. A., Vakharia V. N., Lloyd R. E., Ehrenfeld E., Grubman M. J. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62:1988;4407-4409.
11. Ehrenfeld, E. 1996, Initiation of translation by picornavirus RNAs, Translational Control, 549, 573, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. Etchison D., Fout S. Human rhinovirus 14 infection of HeLa cells results in the proteolytic cleavage of the p220 cap-binding complex subunit and inactivates globin mRNA translation in vitro. J. Virol. 54:1985;634-638.
13. Etchison D., Milburn S. C., Edery I., Sonenberg N., Hershey J. W. B. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eukaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257:1982;14806-14810.
14. Faleiro L., Kobayashi R., Fearnhead H., Lazebnik Y. Multiple species of CPP32 and Mch2 are the active caspases present in apoptotic cells. EMBO J. 16:1997;2271-2281.
15. Haghighat A., Svitkin Y., Novoa I., Kuechler E., Skern T., Sonenberg N. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J. Virol. 70:1996;8444-8450.
16. Haller, A. A. Semler, B. L. 1995, Translation and host cell shutoff, In, Human Enterovirus Infections, 113, 134, ASM Press, Washington, DC.
17. Jones C., Ehrenfeld E. The effect of poliovirus infection on the translation in vitro of VSV messenger ribonucleoprotein particles. Virology. 129:1983;415-430.
18. Kirchweger R., Ziegler E., Lamphear B. J., Waters D., Liebig H. D., Sommergruber W., Sobrino F., Hohenadl C., Blaas D., Rhoads R. E., Skern T. Foot-and-mouth disease virus leader proteinase: Purification of the 1b form and determination of its cleavage site on eIF-4 gamma. J. Virol. 68:1994;5677-5684.
19. Kräusslich H. G., Nicklin M. J. H., Toyoda H., Etchison D., Wimmer E. Poliovirus proteinase 2A induces cleavage of eukaryotic initiation factor 4F polypeptide p220. J. Virol. 61:1987;2711-2718.
20. Lamphear B. J., Kirchweger R., Skern T., Rhoads R. E. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases - Implications for cap-dependent and cap-independent translational initiation. J. Biol. Chem. 270:1995;21975-21983.
21. Lamphear B. J., Yan R. Q., Yang F., Waters D., Liebig H. D., Klump H., Kuechler E., Skern T., Rhoads R. E. Mapping the cleavage site in protein synthesis initiation factor-eIF-4γ of the 2A proteases from human coxsackievirus and rhinovirus. J. Biol. Chem. 268:1993;19200-19203.
22. Liebig H. D., Ziegler E., Yan R., Hartmuth K., Klump H., Kowalski H., Blaas D., Sommergruber W., Frasel L., Lamphear B., Rhoads R., Kuechler E., Skern T. Purification of 2 Picornaviral-2A proteinases - Interaction with eIF-4-γ and influence on in vitro translation. Biochemistry. 32:1993;7581-7588.
23. Lloyd R. E., Bovee M. Persistent infection of human erythroblastoid cells by poliovirus. Virology. 194:1993;200-209.
24. Lloyd R. E., Grubman M. J., Ehrenfeld E. Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequences. J. Virol. 62:1988;4216-4223.
25. Lloyd R. E., Jense H. G., Ehrenfeld E. Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage. J. Virol. 61:1987;2480-2488.
26. Lloyd R. E., Toyoda H., Etchison D., Wimmer E., Ehrenfeld E. Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology. 150:1986;229-303.
27. Ohlmann T., Pain V. M., Wood W., Rau M., Morley S. J. The proteolytic cleavage of eukaryotic initation factor (eIF) 4G is prevented by eIF4E binding protein (PHAS-I, 4E-BP1) in the reticulocyte lysate. EMBO J. 16:1997;844-855.
28. Pérez L., Carrasco L. Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection. Virology. 189:1992;178-186.
29. Pestova T. V., Shatsky I. N., Hellen C. U. T. Functional dissection of eukaryotic initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes. Mol. Cell. Biol. 16:1996;6870-6878.
30. Sommergruber W., Ahorn H., Klump H., Seipelt J., Zoephel A., Fessl F., Krystek E., Blaas D., Kuechler E., Liebig H. D., Skern T. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 γ via a common recognition motif. Virology. 198:1994;741-745.
31. Tolskaya E. A., Romanova L. I., Kolesnikova M. S., Gmyl A. P., Gorbalenya A. E., Agol V. I. Genetic studies on the poliovirus 2C protein, an ntpase - A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization. J. Mol. Biol. 236:1994;1310-1323.
32. Wyckoff E. E., Lloyd R. E., Ehrenfeld E. Relationship of eukaryotic initation factor 3 to poliovirus-induced p220 cleavage activity. J. Virol. 66:1992;2943-2951.
33. Wyckoff E. E., Croall D. E., Ehrenfeld E. The p220 component of eukaryotic initiation factor-4F is a substrate for multiple calcium-dependent enzymes. Biochemistry. 29:1990;10055-10061.